Does CryoLife stock have an upside of 81%?
According to analysts' consensus price target of $32.00, CryoLife has a forecasted upside of 81.5% from its current price of $17.63. CryoLife has only been the subject of 1 research reports in the past 90 days.
Is CryoLife (Cry) a good buy?
CryoLife has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings. According to analysts' consensus price target of $32.00, CryoLife has a forecasted upside of 81.5% from its current price of $17.63.
What are analysts'target prices for CryoLife's stock?
2 analysts have issued twelve-month target prices for CryoLife's stock. Their forecasts range from $25.00 to $39.00. On average, they expect CryoLife's stock price to reach $32.00 in the next year. This suggests a possible upside of 81.5% from the stock's current price.
Who sold their CryoLife shares?
Company insiders that have sold CryoLife company stock in the last year include Amy Horton, David Ashley Lee, Dennis B Maier, Jean F Holloway, John E Davis, Ronald D Mccall, and Thomas A Mccourt. View insider buying and selling activity for CryoLife or view top insider-selling stocks. How do I buy shares of CryoLife?
Should I buy or sell CryoLife stock right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CryoLife in the last year. There are currently 1 hold rating and...
What is CryoLife's stock price forecast for 2022?
2 brokerages have issued 1 year price objectives for CryoLife's stock. Their forecasts range from $25.00 to $39.00. On average, they predict CryoLi...
How were CryoLife's earnings last quarter?
CryoLife, Inc. (NYSE:CRY) issued its earnings results on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share...
Who are CryoLife's key executives?
CryoLife's management team includes the following people: James Patrick Mackin , Chairman, President & Chief Executive Officer David Ashley Lee ,...
What is J. Patrick Mackin's approval rating as CryoLife's CEO?
53 employees have rated CryoLife CEO J. Patrick Mackin on Glassdoor.com . J. Patrick Mackin has an approval rating of 81% among CryoLife's employees.
Who are some of CryoLife's key competitors?
Some companies that are related to CryoLife include Abbott Laboratories (ABT) , Medtronic (MDT) , Stryker (SYK) , Intuitive Surgical (ISRG) ,...
What other stocks do shareholders of CryoLife own?
Based on aggregate information from My MarketBeat watchlists, some companies that other CryoLife investors own include Energy Transfer (ET) , AT&...
What is CryoLife's stock symbol?
CryoLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."
Who are CryoLife's major shareholders?
CryoLife's stock is owned by many different retail and institutional investors. Top institutional investors include PEAK6 Investments LLC (0.00%) a...
NYSE
Environmental, Social, and Governance Rating
The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
